Evaluation of endothelial function in patients with limited systemic sclerosis by use of brachial artery Doppler ultrasound

Revista Brasileira de Reumatologia

Volumn 52, Issue 4, 2012, Pages 561-568

  Fernandes, Tatiana Melo ^a   Bica, Blanca Elena Gomes ^a   Villela, Nivaldo Ribeiro ^a   Salles, Elizabeth Figueiredo ^a   de Azevedo, Mario Newton Leitão ^a   de Souza Papi, José Angelo ^a   Martins, Rosângela Aparecida Gomes ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brachial artery; Doppler effect; Limited scleroderma; Ultrasound; Vascular endothelium

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE; PHOSPHODIESTERASE I INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOPPLER ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE PARAMETERS; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPEREMIA; LIMITED SYSTEMIC SCLEROSIS; LOW DRUG DOSE; MICROVASCULAR ISCHEMIA; NITROGLYCERIN MEDIATED DILATION; OBSERVATIONAL STUDY; OPEN STUDY; PROSPECTIVE STUDY; RED BLOOD CELL VELOCITY; SYSTEMIC SCLEROSIS; VASODILATATION;

ADULT; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; ULTRASONOGRAPHY, DOPPLER;

EID: 84866516843     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0482-50042012000400008     Document Type: Article

References (32)

1. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2003; 2(4):181-91.
2. Abra ham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009; 48(Suppl. 3): iii3-7.
3. Frech T, Hatton N, Markewitz B, Scholand MB, Cawthon R, Patel A et al. The vascular microenvironment and systemic sclerosis. Int J Rheumatol 2010; 2010(pii):362868.
4. Freedman RF, Girgis R, Mayes MD. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma. J Rheumatol 1999; 26(11):2386-8.
5. Kahaleh MB, LeRoy EC. Autoimmunity and vascular involvement in systemic sclerosis (SSc). Autoimmunity 1999; 31(3):195-214.
6. Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys 2004; 23(3):265-95.
7. Kuo L, Davis MJ, Chilian WM. Endothelial modulation of arteriolar tone. News Physiol Sci 1992; 7(1):5-9.
8. Wanstall JC, Homer KL, Doggrell SA. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol 2005; 3(1):41-53.
9. Andersen GN, Mincheva-Nilsson L, Kazzam E, Nyberg G, Klintland N, Petersson AS et al. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 2002; 46(5):1324-32.
10. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46(3):428-40.
11. Constans J, Gosse P, Pellegrin JL, Ansoborlo P, Leng B, Clément J et al. Alteration of arterial distensibility in systemic sclerosis. J Intern Med 1997; 241(2):115-18.
12. Matucci-Cerinic M, Fiori G, Grenbaum E, Shoenfeld Y. Macrovascular disease in systemic sclerosis. 2.ed. Baltimore: Lippincot Williams & Wilkins, 2003.
13. Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am 2008; 34(1):57-71 vi.
14. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340(8828):1111-5.
15. Rollando D, Bezante GP, Sulli A, Balbi M, Panico N, Pizzorni C et al. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 2010; 37(6):1168-73.
16. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91(5):1314-9.
17. Lekakis J, Papamichael C, Mavrikakis M, Voutsas A, Stamatelopoulos S. Effect of long-term estrogen therapy on brachial artery endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis. Am J Cardiol 1998; 82(12):1555-7, A8.
18. Szucs G, Tímár O, Szekanecz Z, Dér H, Kerekes G, Szamosi S et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis - relevance for prevention of vascular complications. Rheumatology (Oxford) 2007; 46(5):759-62.
19. Cypiene A, Laucevicius A, Venalis A, Dadoniene J, Ryliskyte L, Petrulioniene Z et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008; 27(12):1517-22.
20. Rossi P, Granel B, Marziale D, Le Mée F, Francès Y. Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 2010; 30(6):453-9.
21. Rajagopalan S, Pfenninger D, Kehrer C, Chakrabarti A, Somers E, Pavlic R et al. Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease. Arthritis Rheum 2003; 48(7):1992-2000.
22. Roustit M, Simmons GH, Baguet JP, Carpentier P, Cracowski JL. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 2008; 35(8):1576-83.
23. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23(5):581-90.
24. Salles-Cunha SX, Morais Filho D. Princípios básicos. In: Engelhorn CA, Morais Filho D, Barros FS, Coelho N. Guia prático de ultrassonografia vascular. Rio de Janeiro: Dilivros, 2007.
25. D'Andrea A, Stisi S, Caso P, Uccio FS, Bellissimo S, Salerno G et al. Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients. Echocardiography 2007; 24(7):587-97.
26. Bartoli F, Blagojevic J, Bacci M, Fiori G, Tempestini A, Conforti ML et al. Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 2007; 1108:283-90.
27. Youseff P, Brama T, Englert H, Bertouch J. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 1995; 22(3):469-72.
28. Wan MC, Moore T, Hollis S, Herrick AL. Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology (Oxford) 2001; 40(10):1102-5.
29. Cheng KS, Tiwari A, Boutin A, Denton CP, Black CM, Morris R et al. Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 2003; 42(11):1299-305.
30. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ et al. Vascular compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997; 10(10 Pt 1):1175-89.
31. Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J. Brachial artery diameter is related to cardiovascular risk factors and intima-media thickness. Eur J Clin Invest 2009; 39(7):554-60.
32. Doshi S, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ et al. Flowmediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 2001; 101(6):629-35.